Introduction The successful development of therapies for any disease requires support from early stages (basic/fundamental research), through more mature preclinical, translational, or early clinical stages, then more mature clinical stages, and finally, post-marketing studies. How different funders decide when to fund at a given stage in a treatment’s development is fairly opaque. Knowledge of the […]
Grant Funding Opportunity for Rare Diseases Research – Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases
The Food and Drug Administration’s (FDA) Office of Orphan Products Development (OOPD) is pleased to announce availability of funds to support clinical trials for rare diseases and conditions. The purpose of this funding opportunity announcement is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in […]
FDA announces 2022 grant funding opportunity for rare disease research
The Food and Drug Administration’s (FDA) Office of Orphan Products Development (OOPD) is pleased to announce availability of funds for to support natural history studies for rare diseases and conditions. These studies are intended to provide acceptable data to the FDA that will substantially contribute to the approval of new products, or new indications for already marketed […]
FDA announces 2022 grant funding opportunity for rare disease research
The Food and Drug Administration
Orphan Products Natural History Grants: New Funding Opportunity
FDA
Orphan Products Natural History Grants: New Funding Opportunity
FDA’s Office of Orphan Product Development (OOPD) has opened grant opportunity to support efficient and innovative natural history studies that advance medical product development in rare diseases with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to […]
FDA Upcoming Grant Funding Opportunity for Rare Disease Research
The Food and Drug Administration’s (FDA) Office of Orphan Products Development (OOPD) is pleased to announce availability of funds for fiscal years (FY) 2021 – FY 2022 to support innovative and efficient clinical trials for rare diseases and conditions. These studies are intended to provide acceptable data to the FDA that will substantially contribute to the […]
FDA Upcoming Grant Funding Opportunity for Rare Disease Research
The Food and Drug Administration
New grant funding opportunity: FDA OOPD Orphan Products Grants Program
June 23rd 2020 The Food and Drug Administration’s (FDA) Office of Orphan Products Development (OOPD) is pleased to announce availability of funds for fiscal years (FY) 2021 – FY 2022 to support innovative and efficient clinical trials for rare diseases and conditions. These studies are intended to provide acceptable data to the FDA that will […]
New grant funding opportunity: FDA OOPD Orphan Products Grants Program
June 23rd 2020 The Food and Drug Administration